Want to see AU:BMT full AI Analyst Report?

Beamtree Holdings Ltd (BMT) Price & Analysis

13 Followers

BMT Stock Chart & Stats

AU$0.14

AU$0.00(0.00%)

At close: Jul 24 4:00 PM EDT

AU$0.14

AU$0.00(0.00%)

Day’s Range― - ―

52-Week RangeAU$0.08 - AU$0.30

Previous CloseN/A

Volume3.60K

Average Volume (3M)122.51K

Market Cap

AU$39.24M

Enterprise ValueAU$44.31M

Total Cash (Recent Filing)AU$2.94M

Total Debt (Recent Filing)AU$3.65M

Price to Earnings (P/E)―

Beta0.90

Next Earnings

Aug 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding290,696,170

10 Day Avg. Volume152,204

30 Day Avg. Volume122,509

Financial Highlights & Ratios

PEG Ratio-0.66

Price to Book (P/B)1.72

Price to Sales (P/S)2.53

P/FCF Ratio-39.18

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)>-0.01

Revenue Forecast (FY)AU$34.83M

Bulls Say, Bears Say

Bulls Say

High Gross MarginA 100% gross margin reflects the software-centric business model with minimal direct cost of goods sold. This provides durable operating leverage: if the company stabilises sales and controls operating expenses, high gross margins can convert to sustainable profitability over time.

Conservative LeverageLow debt-to-equity reduces refinancing and solvency risk, preserving strategic flexibility. With weak cash flow, conservative leverage limits bankruptcy risk and allows management to pursue product development or M&A without immediate heavy interest burdens.

Specialised Clinical Software Product SetFocus on clinical decision support, coding automation and NLP targets structural healthcare digitisation trends. This niche in acute-care workflows supports recurring contracts and strong customer switching costs, underpinning durable revenue potential if product-market fit and adoption continue.

Bears Say

Negative ProfitabilityPersistent negative EBIT and net margins indicate the core business is not yet self-sustaining. Over months, continued operating losses will erode equity, force cost cutting or dilution, and limit reinvestment into sales and product development needed to scale.

Poor Cash GenerationNegative free cash flow and weak operating cash conversion create liquidity pressure that can necessitate external financing. This constrains long-term investment in R&D and sales expansion, raising execution risk during the multi-quarter transition to profitability.

Revenue Growth DeteriorationA turn to negative revenue growth signals demand or competitive issues in core hospital markets. Sustained declines impair scale economics and make margin recovery harder, potentially requiring price/revenue strategy shifts or increased sales investment to regain momentum.

Beamtree Holdings Ltd News

Beamtree issues over 1.1m new shares under cleansing notice

Beamtree Holdings Ltd ( ($AU:BMT) ) just unveiled an update. Beamtree Holdings has issued 1,167,761 fully paid ordinary...

4d ago

BMT

Beamtree Seeks ASX Quotation for 1.17 Million New Shares

An update from Beamtree Holdings Ltd ( ($AU:BMT) ) is now available. Beamtree Holdings Ltd has applied for...

4d ago

BMT

Beamtree Plans Share Placement of Over 1.1 Million New Shares

The latest update is out from Beamtree Holdings Ltd ( ($AU:BMT) ). Beamtree Holdings Ltd has notified the...

7d ago

BMT

Beamtree Lifts Equity Sign-On Grant for New CEO Gareth Pye

Beamtree Holdings Ltd ( ($AU:BMT) ) has issued an announcement. Beamtree Holdings Limited has revised the sign-on equity...

7d ago

BMT

Beamtree Discloses Board Change as Director James Birch Steps Down

Beamtree Holdings Ltd ( ($AU:BMT) ) has shared an announcement. Beamtree Holdings Limited has announced that James Birch...

1M ago

BMT

Beamtree Director Bradley Lancken Steps Down but Retains Indirect Stake

Beamtree Holdings Ltd ( ($AU:BMT) ) has issued an update. Beamtree Holdings Limited has announced the cessation of...

1M ago

BMT

Beamtree Director Mike Hill Increases Indirect Shareholding via Super Fund

The latest announcement is out from Beamtree Holdings Ltd ( ($AU:BMT) ). Beamtree Holdings Limited has reported a...

1M ago

BMT

Beamtree Issues 2 Million Unquoted Performance Rights Under Incentive Scheme

An announcement from Beamtree Holdings Ltd ( ($AU:BMT) ) is now available. Beamtree Holdings Limited has issued 2,000,000...

3M ago

BMT

Beamtree Performance Rights Lapse After Vesting Conditions Not Met

An announcement from Beamtree Holdings Ltd ( ($AU:BMT) ) is now available. Beamtree Holdings Ltd has announced the...

3M ago

BMT

Beamtree Issues 770,000 Unquoted Performance Rights Under Employee Incentive Scheme

Beamtree Holdings Ltd ( ($AU:BMT) ) just unveiled an announcement. Beamtree Holdings Ltd has issued 770,000 unquoted performance...

3M ago

BMT

BMT FAQ

What was Beamtree Holdings Ltd’s price range in the past 12 months?

Beamtree Holdings Ltd lowest share price was AU$0.08 and its highest was AU$0.29 in the past 12 months.

What is Beamtree Holdings Ltd’s market cap?

Beamtree Holdings Ltd’s market cap is AU$39.24M.

When is Beamtree Holdings Ltd’s upcoming earnings report date?

Beamtree Holdings Ltd’s upcoming earnings report date is Aug 26, 2026 which is in 19 days.

How were Beamtree Holdings Ltd’s earnings last quarter?

Beamtree Holdings Ltd released its earnings results on Feb 18, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.01.

Is Beamtree Holdings Ltd overvalued?

According to Wall Street analysts Beamtree Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Beamtree Holdings Ltd pay dividends?

Beamtree Holdings Ltd does not currently pay dividends.

What is Beamtree Holdings Ltd’s EPS estimate?

Beamtree Holdings Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Beamtree Holdings Ltd have?

Beamtree Holdings Ltd has 290,696,170 shares outstanding.

What happened to Beamtree Holdings Ltd’s price movement after its last earnings report?

Beamtree Holdings Ltd reported an EPS of -AU$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Beamtree Holdings Ltd?

Currently, no hedge funds are holding shares in AU:BMT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Beamtree Holdings Ltd Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-5.78%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Beamtree Holdings Ltd

Headquartered in Redfern, Australia, Beamtree Holdings Limited, founded in 1996, develops and markets cutting-edge clinical decision support (CDS) solutions for the healthcare sector, both within Australia and globally. The company offers a diverse range of products aimed at improving operational accuracy and patient outcomes. Among these are RippleDown Expert, providing live patient monitoring and notification capabilities, and RippleDown Auditor, which automates real-time data verification to ensure precision in billing, data entry, and specimen reception while identifying potential errors. Beamtree also offers PICQ, a quality assessment tool for clinically coded data used by public and private hospitals, health services, and state health authorities, alongside RISQ, designed for the measurement, benchmarking, and management of hospital-acquired complications. Further expanding its suite, the Q Coding Platform delivers an end-to-end workflow for clinical coding, grouping, reporting, and auditing, supported by Codexpert, a digital reference application for classification information in patient records. Additionally, the company provides expert advisory and auditing services, such as desktop analysis, data maturity assessments, and physical audits, reaching its clientele through strategic channel partners. The company adopted its current name, Beamtree Holdings Limited, in August 2021, having previously been known as PKS Holdings Limited.